Danaher Prices Public Offering at $51.75 per Share | GenomeWeb

The story has been updated to include the net proceed anount if underwriters exercise their over-allotment option in full.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher late on Tuesday priced its public offering of 17.5 million shares of its common stock at $51.75 per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.